RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$205.15
+7.34 (+3.71%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+109.36%
1Y
+491.21%
YTD
+159.62%
Open$200.82
Previous Close$197.81
Day High$205.90
Day Low$196.49
52W High$203.00
52W Low$34.00
Volume—
Avg Volume1.79M
Market Cap43.85B
P/E Ratio—
EPS$-4.80
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$94.85
Above
SMA 200
$58.23
Above
RSI (14)
62.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
-44.4% upside
Current
$205.15
$205.15
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.27B | 6.60B | 6.07B |
| Net Income | 320.45M | 295.32M | 319.17M |
| Profit Margin | 4.4% | 4.5% | 5.3% |
| EBITDA | 413.26M | 366.06M | 402.03M |
| Free Cash Flow | 328.07M | 289.36M | 393.55M |
| Rev Growth | +0.4% | +7.5% | +13.8% |
| Debt/Equity | 0.86 | 0.80 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |